Abstract
The mutant mouse strain HPH2 (hyperphenylalaninemia) was isolated after N-ethyl-N-nitrosourea (ENU) mutagenesis on the basis of delayed plasma clearance of an injected load of phenylalanine. Animals homozygous for the recessive hph2 mutation excrete elevated concentrations of many of the neutral amino acids in the urine, while plasma concentrations of these amino acids are normal. In contrast, mutant homozygotes excrete normal levels of glucose and phosphorus. These data suggest an amino acid transport defect in the mutant, confirmed in a small reduction in normalized values of 14C-labeled glutamine uptake by kidney cortex brush border membrane vesicles (BBMV). The hyperaminoaciduria pattern is very similar to that of Hartnup Disorder, a human amino acid transport defect. A subset of Hartnup Disorder cases also show niacin deficiency symptoms, which are thought to be multifactorially determined. Similarly, the HPH2 mouse exhibits a niacin-reversible syndrome that is modified by diet and by genetic background. Thus, HPH2 provides a candidate mouse model for the study of Hartnup Disorder, an amino acid transport deficiency and a multifactorial disease in the human.
Similar content being viewed by others
References
Aronson PS, Sactor B (1975) The Na+ gradient-dependent transport of D-glucose in renal brush border membranes. J Biol Chem 250, 6032–6039
Asatoor AM, Craske J, London DR, Milne MD (1963) Indole production in Hartnup Disorder. Lancet 1, 126
Baron DN, Dent CE, Haris H, Hart EW, Jepson JB (1956) Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal aminoaciduria, and other bizarre biochemical features. Lancet 2, 421–428
Bergeron M, Gougoux A (1989) The renal Fanconi syndrome. In The Metabolic Basis of Inherited Disease, CR Scriver, AL Beaudet, WS Sly, D Valle, eds. (New York: McGraw-Hill) pp. 2569–2580
Chesney, R (1995) Iminoglycinuria, In The Metabolic and Molecular Bases of Inherited Disease, CR Scriver, AL Beaudet, WS Sly, D Valle, eds. (New York: McGraw-Hill) pp. 3643–3654
Christensen, HN (1989) Distinguishing amino acid transport systems of a given cell or tissue. Methods Enzymol 173, 576–616
Christensen, HN (1990) Role of amino acid transport and counter transport in nutrition and metabolism. Physiol Rev 70, 43–77
Curriden, S, Englesberg, E (1981) Inhibition of growth of proline-requiring Chinese hamster ovary cells (CHO-K1) resulting from antagonism by A system amino acids. J Cell Physiol 106, 245–252
Dillehay, AL, Bass, R, Englesberg, E (1980) Inhibition of growth cells in culture by L-phenylalanine as a model system for the analysis of phenylketonuria. I. Amino acid antagonism and the inhibition of protein synthesis. J Cell Physiol 102, 395–405
Evered, DF (1956) The excretion of amino acids by the human. Biochem J 62, 416–427
Evers, J, Murer, H, Kinne, R (1976) Phenylalanine uptake in isolated renal brush border vesicles. Biochim Biophys Acta 426, 598–615
Forbush, B (1983) Assay of Na, K-ATPase in plasma membrane preparations: increasing the permeability of membrane vesicles using sodium dodecyl sulfate buffered with bovine serum albumin. Anal Biochem 128, 159–163
George, SG, Kenny, AJ (1973) Studies on the enzymology of purified preparations of brush border from rabbit kidney. Biochem J 134, 43–57
Groth, U, Rosenberg, LE (1972) Transport of dibasic amino acids, cystine, and tryptophan by cultured human fibroblasts: absence of a defect in cystinuria and Hartnup disease. J Clin Invest 51, 2130–2142
Guillery, EN, Karniski, LP, Matthews, MS, Robillar, JE (1994) Maturation of proximal tubule Na+/H+ antiporter activity in sheep during transition from fetus to newborn. Am J Physiol 267, F537-F545
Halvorsen, S, Hygstedt, O, Jagenburg, R, Sjaastad, O (1969) Cellular transport of L-histidine in Hartnup disease. J Clin Invest 48, 1552–1559
Heinz, E, Weinstein, AM (1984) The overshoot phenomenon in cotransport. Biochim Biophys Acta 776, 83–91
Kinsella, JL, Aronson, PS (1980) Properties of the Na+-H+ exchanger in renal microvillus membrane vesicles. Am J Physiol 238, F461-F469
Lemieux, B, Auray-Blais, C, Giguere, R, Shapcott, D, Scriver, CR (1988) Newborn urine screening experience with over one million infants in Quebec Network of Genetic Medicine. J Inherited Metab Dis 11, 45–55
Les, EP (1966) Husbandry. In Biology of the Laboratory Mouse, EL Green, ed. (New York: McGraw-Hill) pp. 29–37
Levy, HL (1995) Hartnup Disorder, In The Metabolic and Molecular Bases of Inherited Disease, CR Scriver, AL Beaudet, WS Sly, D Valle, eds. (New York: McGraw-Hill) pp. 3629–3642
Lowry, OH, Rosenbaugh, NH, Farr, AL, Randall, RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265–275
McDonald, JD, Bode, VC (1988) Hyperphenylalaninemia in the hph-1 mouse mutant. Pediatr Res 23, 63–67
McDonald, JD, Bode, VC, Dove, WF, Shedlovsky, A (1990) Pah hph-5: a mouse mutant deficiency in phenylalanine hydroxylase. Proc Natl Acad Sci USA 87, 1965–1967
McKean, CM, Boggs, DE, Peterson, NA (1968) The influence of high phenylalanine and tyrosine on the concentrations of essential amino acids in brain. J Neurochem 15, 235–241
Mircheff, AK, Kippen, I, Hirayama, B, Wright, EM (1982) Delineation of sodium-stimulated amino acid transport pathways in rabbit kidney brush border vesicles. J Membr Biol 64, 113–122
Nielsen, EG, Vedso, S, Zimmmerman-Nielsen, C (1966) Hartnup disease in three siblings. Dan Med Bull 13, 155–161
Olendorf, WH (1973) Saturation of blood brain barrier transport of amino acid in phenylketonuria. Arch Neurol 28, 45–48
Oxender, DL, Christensen, HN (1963) Distinct mediating systems for the transport of neutral amino acids by the Ehrlich cell. J Biol Chem 238 3686–3699
Peterson, GL (1977) A simplification of the protein assay method of Lowery et al. which is more generally applicable. Anal Biochem 83, 346–356
Pomeroy, J, Efron, ML, Dayman, J, Hoefnagal, D (1968) Hartnup Disease in a New England family. N Engl J Med 278, 1214–1216
Pontoglio, M, Barra, J, Hadchouel, M, Doyen, A, Kress, C, Bach, JP, Babinet, C (1996) Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 84, 575–585
Reizer, J, Reizer, A, Saier, MH (1994) A functional superfamily of sodium/ solute symporters. Biochim Biophys Acta 1197, 133–166
Scriver, CR (1965) A genetic modification of intestinal and renal transport of certain neutral alpha-amino acids. N Engl J Med 273, 530–532
Scriver, CR (1988) Nutrient-gene interactions: the gene is not the disease and vice-versa. Am J Clin Nutr 48, 1505–1509
Scriver, CR, Mahon, B, Levy, HL, Clow, CL, Reade, TM, Kronick, J, Lemieux, B, Laberge, C (1987) The Hartnup phenotype: Mendelian transport disorder, multifactorial disease. Am J Hum Genet 40, 401–412
Seakins, JWT (1977) Hartnup disease. In Metabolic and Deficiency diseases of the Nervous System, PJ Vinken, GW Bruyn, eds. (Amsterdam, North-Holland) pp. 149–170
Segal, S, Thier, SO (1995) Cystinuria. In Metabolic and Molecular Bases of Inherited Disease, CR Scriver, AL Beaudet, WS Sly, D Valle, eds. (New York: McGraw-Hill), pp. 3581–3602
Shaw, KNF, Redlich, D, Wright, SW, Jepson, JB (1960) Dependence of urinary indole excretion in Hartnup disease upon gut flora. Fed Proc 19, 194
Shedlovsky, A, McDonald, JD, Symula, D, Dove, WF (1993) Mouse models of phenylketonuria. Genetics 134, 1205–1210
Shih, VE, Bixby, EM, Alpers, DH, Bartsocas, CS, Thier, SO (1971) Studies of intestinal transport defect in Hartnup disease. Gastroenterology 61, part 1, 445–453
Silbernagl, S (1992) Amino acids and oligopeptides, In The Kidney: Physiology and Pathophysiology, 2nd ed., DW Seldin, G Giebisch, eds. (New York: Raven Press, Ltd.) pp. 2889–2920
Simell, O (1995) Lysinuric protein intolerance and other cationic aminoacidurias, In The Metabolic and Molecular Bases of Inherited Disease, CR Scriver, AL Beaudet, WS Sly, D Valle, eds. (New York: McGraw-Hill) pp. 3603–3628
Slocum, RH, Cummings, JG (1991) Amino acid analysis of physiological samples. In Diagnostic Human Biochemical Genetics, FA Hommes, ed. (New York: Wiley-Liss) pp. 87–126
Symula, DJ, Shedlovsky, A, Dove, WF (1996). Genetic mapping of hph2, a mutation affecting amino acid transport in mouse. Mamm Genome, 8, 98–101
Tada, K, Morikawa, T, Arakawa, T (1966) Tryptophan load and uptake of tryptophan by leukocytes in Hartnup disease. Tohoku J Exp Med 90, 337–346
Tarlow, MJ, Seakins, WT, Lloyd, JK, Cheng, B, Thomas, AJ (1972) Absorption of amino acids and peptides in a child with a variant of Hartnup Disease and coexistent coeliac disease. Arch Dis Child 47, 798–803
Wilcken, B, Yu, JS, Brown, DA (1977) Natural history of Hartnup disease. Arch Dis Child 52, 38–40
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Symula, D.J., Shedlovsky, A., Guillery, E.N. et al. A candidate mouse model for Hartnup Disorder deficient in neutral amino acid transport. Mammalian Genome 8, 102–107 (1997). https://doi.org/10.1007/s003359900367
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s003359900367